Tirzepatide, a drug for diabetes and obesity, has sent the 148-year-old pharma giant on a wild ride. It’s now the ninth most valuable company in the world.
In a world of fast-advancing technology and precision medicine, are our primate relatives really the best tool for developing and testing human medicines?
Research from the Kaiser Family Foundation shows that Black, Hispanic, and Asian adults with mental health problems are less likely to receive treatment than their white counterparts.
The companies and their rivals say their enormous size and scope makes them the best candidates to fix America’s health care system. After a new wave of mergers, they’re under pressure to prove it.
HCA reported record profits during the pandemic. But patients and providers at one of the company’s recent acquisitions say financial returns and quality care are two very different things.
HCA Healthcare is being criticized by the SEIU over its emergency room admissions—an area where for-profit hospitals have gotten in trouble in the past.